HomeNewsBusinessBuy Glenmark Pharma, Ajanta Pharma, Cipla: Ashwani Gujral

Buy Glenmark Pharma, Ajanta Pharma, Cipla: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com recommends buying Glenmark Pharma, Ajanta Pharma and Cipla.

September 21, 2017 / 14:50 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "I think there is only one game in town today which is pharmaceutical. So, Glenmark Pharma is a buy with a stop loss of Rs 615 and target of Rs 670."

"Ajanta Pharma is a buy with a stop loss of Rs 1,220 and target of Rs 1,265. Cipla is a buy with a stop loss of Rs 580 and target of Rs 615," he added.

Story continues below Advertisement
first published: Sep 21, 2017 02:47 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!